Business Wire

Nordtreat Has Appointed Outi Kallio as the New CEO

Share

The Finnish technology company Nordtreat strengthens its growth by appointing Outi Kallio as the new CEO. Her era at Nordtreat will start from the turn of 2024/2025. Outi Kallio has a wealth of experience in commercial and industrial management, having held several key positions at Teknos Group.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240902513997/en/

The Finnish technology company Nordtreat strengthens its growth by appointing Outi Kallio as the new CEO. (Photo: Business Wire)

Outi Kallio has an extensive background in sales, HR, and marketing. She also has a proven track record of leading international teams. Currently, she holds the position of Global Commercial Director at Teknos Group.

"As Nordtreat continues to grow and evolve, we are thrilled to welcome Outi Kallio as our new CEO. Her diverse experience and proven leadership skills make her the ideal candidate to lead Nordtreat into its next chapter. We believe that Outi Kallio’s strategic vision and operational expertise will drive our company forward and enhance shareholder value," says Leif Frilund, Chairman of the Board of Nordtreat.

"With over a decade of experience in the coatings industry, I have seen a growing shift towards sustainable solutions, driven by increasing customer expectations. Nordtreat's commitment to bio-based technologies and its strong ethos of responsibility provides a solid foundation for scaling Finnish sustainability expertise into an international growth story. I am excited to join this team of top professionals and look forward to contributing to our shared success," Outi Kallio says.

As Nordtreat’s CEO, Outi Kallio will succeed Aki Borgentorp, who has led the company for ten years. These years have included the development of the first truly bio-based flame retardant for wood-based materials and the growth of a worldwide market presence.

"Over the past decade, Nordtreat has built a scalable platform for the development and production of bio-based flame retardants for wood-based materials. I am convinced that under Outi Kallio’s leadership, Nordtreat will continue to innovate and expand its presence in the market and make a significant impact in the construction materials industry," says Aki Borgentorp.

"On behalf of the Nordtreat board, I’d like to express our sincere gratitude to Aki Borgentorp for his remarkable achievement in building Nordtreat from scratch into a leading provider of new sustainable flame-retardant solutions. We wish Aki the best of success in his future endeavours," Leif Frilund says.

Nordtreat has also welcomed Dr Thomas Kostka, the Head of Corporate Venturing at Altana AG, to join the board of directors starting in August 2024. Additionally, Nordtreat has appointed Sakari Saarela, a partner in the UB FIGG Fund, as a board observer. Sampsa Auvinen, who has been on Nordtreat's board since 2022, will continue as UB FIGG's representative on the board. Sampsa Auvinen is also the Chairman of the Advisory Board of UB FIGG. Altana Group, the global leader in true specialty chemicals, and the Finnish sustainability fund UB Forest Industry Green Growth Fund (UB FIGG), a growth private equity fund investing in sustainable and resource-efficient forest and bio-based industries, announced an investment in Nordtreat in June 2024.

"We are happy to welcome Thomas Kostka to the board of directors at Nordtreat. He brings us a deep understanding of the industry and strategic insights that will be invaluable as we continue to grow," says Leif Frilund.

Image folder

Nordtreat is a Finnish technology company founded in 2015, specializing in the development and production of environmentally friendly, high-performance flame retardants. Utilizing bio-based raw materials, Nordtreat's products comply with the latest fire protection regulations and have been used to protect over 2000 buildings worldwide. The company's flagship technology, NORFLAM®, is designed to provide superior fire protection while maintaining environmental sustainability. Nordtreat's innovative solutions are aimed at meeting the growing global demand for safer, more sustainable construction materials. www.nordtreat.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20240902513997/en/

Contacts

Leif Frilund
Chairman, Nordtreat
leif.frilund@walki.com
+358403543330

Aki Borgentorp
CEO, Nordtreat
aki.borgentorp@nordtreat.com
+358 400 366801

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s CDK2 Inhibitor INCB123667 Shows Promising Evidence of Clinical Activity in Patients with Advanced Solid Tumors, Notably Ovarian Cancer14.9.2024 18:45:00 CEST | Press release

Incyte (Nasdaq:INCY) today announced new early clinical data for INCB123667, a highly selective, potential first-in-class CDK2 inhibitor, in patients with advanced solid tumors. The trial results, presented during a mini-oral presentation at the European Society of Medical Oncology (ESMO) with new, updated data shared during the Company’s investor event, highlight the potential of INCB123667 as a differentiated treatment option for cancers with increased Cyclin E1 activity, amplification and/or overexpression in cells predictive of CDK2 dependency. In the trial, patients with advanced or metastatic solid tumors (n=205) – including ovarian cancer, endometrial cancer, gastrointestinal cancer, HR+/HER2- breast cancer and triple negative breast cancer, among others – received varying doses of INCB123667 ranging from 50mg to 150mg using once-daily (QD) and twice-daily (BID) dosing schedules. New data from the Phase 1b dose expansion portion of the trial (data cut-off August 26, 2024) presen

Incyte’s Retifanlimab (Zynyz ® ) Extends Progression-Free Survival in Patients with Squamous Cell Anal Carcinoma (SCAC); Data Featured at ESMO 2024 Presidential Symposium14.9.2024 16:30:00 CEST | Press release

Incyte (Nasdaq:INCY) today announced results from the Phase 3 POD1UM-303/InterAACT2 trial of retifanlimab (Zynyz®), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with platinum-based chemotherapy (carboplatin–paclitaxel) for the treatment of adults with inoperable locally recurrent or metastatic squamous cell anal carcinoma (SCAC). These data were featured today in a Presidential Symposium (LBA 2) at the European Society for Medical Oncology (ESMO) Congress 2024, held in Barcelona and virtually. The POD1UM-303/InterAACT2 trial results build on previously announced topline results, showing that the study met its primary endpoint by demonstrating a statistically significant and clinically meaningful improvement in progression-free survival (PFS) in patients with SCAC not previously treated with systemic therapy, as assessed by blinded independent central review (BICR) using RECIST v1.1. Adding retifanlimab to standard of care chemotherapy res

Irdeto Partners with Bitmovin to Deliver Industry-Leading Secure Low-Latency Streaming with Unmatched User Experience14.9.2024 10:00:00 CEST | Press release

Irdeto, the global leader in digital video platform experiences and security, and Bitmovin, the industry leader in video software solutions, today announced a strategic partnership to deliver enhanced secure video streaming experiences. This collaboration integrates Bitmovin’s renowned Player and Analytics suite into Irdeto Experience, the award-winning streaming platform trusted by top-tier operators worldwide. Together, they will provide streaming service providers, content owners, and pay-TV operators with cutting-edge solutions that address the critical need for low-latency streaming. The combination of Irdeto’s expertise in security and Bitmovin’s preeminent player offers a powerful and comprehensive solution. This joint offering allows operators to benefit from smooth, high-resolution streaming and advanced advertising and security features. The collaboration also enables operators to extend device reach by covering a wider range of devices in the Smart TV market. Whether for liv

SCF Acquires Newpark Fluids Systems14.9.2024 02:40:00 CEST | Press release

SCF Partners, Inc. (“SCF”) is pleased to announce its acquisition of the Newpark Fluids Systems business (“NFS”), a leading global pure-play oil & gas and geothermal fluids solution provider, from Newpark Resources Inc. (NYSE: NR). Newpark Fluids Systems provides a full range of drilling & completion products and related technical services supported by an innovative digital modeling software suite, global supply chain and infrastructure to enhance the efficiency and productivity of our customers’ performance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240913427560/en/ Newpark Fluid Systems’ CEO, David Paterson, commented, “We are thrilled to partner with SCF. This new partnership will be a source of enormous value creation for both our customers and the entire Newpark Fluids Systems team. Our global strategic growth plan will now accelerate under a new and focused board with significant energy experience and commitment.

Important Looking Pirates Wins Its Third Creative Arts Emmy Award for Its Work on the FX Series Shōgun13.9.2024 18:00:00 CEST | Press release

Philip Engström, VFX Supervisor and Chelsea Mirus, VFX Production Manager represented Important Looking Pirates (“ILP”) on the Shōgun ballot at the award ceremony in Los Angeles, winning the Emmy in the Special Visual Effects In A Season Or A Movie category. ILP had the honour of contributing to 7 out of the 10 episodes for the FX series, which was led by overall VFX supervisor Michael Cliett, and won a record-breaking 14 Creative Arts Emmy awards and is poised to extend that streak at the Primetime Emmys later this week. With an emphasis on historical authenticity, ILP was responsible for large-scale full CG environments, vast crowd work, a devastating landslide and sweeping marine simulations. In addition to Shōgun, ILP was recognized with nominations for 2 of the remaining 4 visual effects nominees at this year’s awards: Netflix’s Avatar: The Last Airbender with Niklas Jacobson as VFX Supervisor and Amazon’s Fallout with Ahmed Gharraph as VFX Supervisor. Additionally, the studio was

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye